KA-PHARMA
Board
1 director, since incorporationDirector (not named in the articles)
appointed by deed of 13-02-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 16-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 13-02-2024
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 09-02-2024 to date
Control
Founder
This company
KA-PHARMA
Equity €157,474
Profit €48,527 in 2025
Capital
- Contribution
- €3,000
- Shares
- 100
- Contribution per share
- €30
- Equity per share
- €1,575 in 2025
- Source
- deed of 13-02-2024
Articles of association
deed of 13-02-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Rémunération des administrateurs, si rémunéré, assemblée générale statuant à la majorité absolue des voix, ou l'actionnaire unique…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “TITRE V. ASSEMBLEE GENERALE Article 17. Tenue et convocation Il est tenu chaque année, au siège ou à l'endroit indiqué dans les…”
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
At incorporation
deed of 13-02-2024 ↗
- 100 shares (100%) · €3,000 in cash